Newly approved : Not sure if this recently... - CLL Support

CLL Support

23,339 members40,047 posts

Newly approved

Survivor1951 profile image
5 Replies

Not sure if this recently approved combination treatment is the same as the aforementioned one because I couldn’t find a reference to 17p deletion in this one, but strides in the making just the same!

pharmacytimes.com/news/comb...

Written by
Survivor1951 profile image
Survivor1951
To view profiles and participate in discussions please or .
5 Replies
Spacee profile image
Spacee

Fabulous news. Hope it is affordable. I realize one might well need financial aid but it has been posted here that help is available. I

don’t know if my 17p- would qualify but he is going to start a somewhat

similar trial with Pembrolizumab and Ibrutinib. I think anything that ends in mab is a humanized cell. And could have similar results. Hope so!

Survivor1951 profile image
Survivor1951 in reply toSpacee

The thing that concerns me with this approval is that it refers to it being an appropriate option for “untreated” CLL patients, so having been on Imbruvica for a year, does that knock me out of eligibility, or am I misunderstanding?

Justasheet1 profile image
Justasheet1 in reply toSurvivor1951

Find it on Clinicaltrials.gov

Jeff

Spacee profile image
Spacee in reply toJustasheet1

Surprised the heck out of me that Huntsville, AL has a CLL trial. I’m from Birmingham and lived in Huntsville when first married. Not

to criticize Huntsville, just thought Univ. of Alabama B’ham was more known for studies.

They might have some, I didn’t peruse the entire 175 studies!

Great info, Jeff!

cllady01 profile image
cllady01Former Volunteer in reply toSurvivor1951

Survivor, it is a matter of having an alternative to Obinituzumab (CD20 targeting) and Chlorambucil (an old chemotherapy)--the combination of which has been a less invasive possibility with a 6 month duration.

This regimen will be at least a year, using Venetoclax (BCL targeting) rather than the chemotherapy, but still get a shorter time for treatment.

For untreated elderly CLL patients, there is now a choice for a shorter term treatment that "should" be a bit less expensive than the long-term treatments of other regimens. I will be watching for the efficacy of the treatment and its side effects with specific co-morbidities/profiles/ages

Not what you're looking for?

You may also like...

V + O frontline approved by FDA

Thank you to all of those participating in clinical trials!...
avzuclav profile image

Frontline Venetoclax/Obinutuzumab Approved in Europe for CLL

In some welcome good news, "The European Commission has approved a fixed-dose combination of...
AussieNeil profile image
Partner

Venetoclax plus obinutuzumab - the first chemotherapy-free, fixed-duration first line CLL treatment approved by Health Canada

* VENCLEXTA® (venetoclax) plus obinutuzumab is the first chemotherapy-free, fixed-duration...
AussieNeil profile image
Partner

Obinutuzumab was approved for treatment naive patients, but in only in combination with chlorambucil.

Friends Obinutuzumab was approved for treatment naive patients, but in only in combination with...
bkoffman profile image
CLL CURE Hero

Newly diagnosed

Found this site today when looking up some health concerns. Reading with tears in my eyes as I see...
Hallyho profile image

Moderation team

See all
AussieNeil profile image
AussieNeilAdministrator
Newdawn profile image
NewdawnAdministrator
CLLerinOz profile image
CLLerinOzAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.